Excelsior Medical Co., Ltd. · TWSE:4104

Excelsior Medical — Investor Conference 2026

19 slides from Excelsior Medical's conference presentation, May 27, 2026

  1. Slide 1: Excelsior Medical Co., Ltd. Investor Conference

    Excelsior Medical Co., Ltd. Investor Conference 2026/5/27

  2. Slide 2: Disclaimer

    Disclaimer This presentation is prepared according to the audited or reviewed financial statements by CPA and the financial figures hereby are based on IFRS, please refer to the published financial statements for full content. The presentation may contain forward-looking information and may differ m

  3. Slide 3: The Business Types

    The Business Types Hemodialysis Aesthetic Medical Trading Business Medical Devices Medical Consumables Home Appliances Product Planning Sales Information Analysis Promotion Hemodialysis channel Pharma. Sales and Promotion Market Creative Aesthetic Medical channel Pharma. Distribution and Logistics M

  4. Slide 4: Revenue Overview

    Revenue Overview Excelsior yearly consolidated sales is more than NT $ 8.7 billion in 2025, the primary revenue comes from Excelsior (Hemodialysis), Dynamic (Aesthetic Medical), Arich (Pharmaceutical Logistics) and others. According to the company’s function, the business type can be characterized a

  5. Slide 5: Operating Overview

    Operating Overview Unit: NTD in thousands 5

  6. Slide 6: Investment Overview

    Investment Overview Unit: NTD in thousands 6

  7. Slide 7: Profit after Tax Overview

    Profit after Tax Overview Unit: NTD in thousands/ EPS: NTD in Dollars 7

  8. Slide 8: Balance Sheet

    Balance Sheet JAssetts ee C—i‘“‘“CSCSC*S*C*‘*C 3,077,674 2,847,128 4,189,204 2,077,747 1,957,907 1,945,932 3,228,751 3,250,068 3,661,059 | _Inventories C—C“‘CSCidC 1,408,900 1,391,669 1,392,801 1,020,203 919,520 1,031,944 10,813,275 10,366,292 12,220,940 other comprehensive income 4,319,876 4,216,10

  9. Slide 9: Balance Sheet

    Balance Sheet 386,784 1,343,221 917,531 1,119,127 1,146,354 978,970 3,677,404 2,596,329 5,307,269 1,159,582 1,106,099 1,084,891 6,342,897 6,192,003 8,288,661 350,000 350,000 - 715,742 710,587 721,987 1,065,742 1,060,587 721,987 7,408,639 7,252,590 9,010,648 Equity Attributable to Owners of Parent 1,

  10. Slide 10: Statement of Comprehensive Income

    Statement of Comprehensive Income 10

  11. Slide 11: Statements of Cash Flows

    Statements of Cash Flows [Unit:In thousands NTD.—“‘“‘;*™*™SCé2ODWGV QA] 2025 | 024 Profit before tax Cash Flows from Operating A es Other receivables Other payables Net Cash Flows from (used in) Operating Activities 293,936 1,181,907 1,174,362 (12,886) (138,064) (99,191) (108,483) 34,337 16,289 22,8

  12. Slide 12: Statements of Cash Flows

    Statements of Cash Flows [Unit:In thousands NTD.—“(‘ts™C™C™~*~*~C~C~C~C~C~C~*LCCi2026Q =| 2025 S| 2024 Cash Flows from Investing Activities Acquisition of financial assets at fair value Proceeds from disposal of financial assets at fair value through profit or loss Proceeds from disposal of financia

  13. Slide 13: Statements of Cash Flows

    Statements of Cash Flows Unit: In thousands NTD—SSCSCSCSS2026Q1 =| 2025 | 20204 (e) (956,437) 425,690 (217,356) - 350,000 - - (620,910) (591,344) Proceeds from disposal of ownership interests _ _ 459.086 in subsidiaries (Not losing control , 1,008,000 - : | Others —“—‘“*™*™*~*~:~”C”CCC‘idC (45,327)

  14. Slide 14: Sustainability Report

    =e8 Excelsior Healtheare Group FT) (es (ee gs 2024 KR Sustainability Report A eS Dh RRS EM LBM BIAS) sO 14064-1:2018 Sustainability Report y a AAI000 Licensed Report (000-250/V2-J628U eA WW): 14

  15. Slide 15: Growing up with Long-term partners

    Growing up with Long-term partners Excelsior has been operating for 30 years, accumulated core competitiveness with new ideas created, new models to integrate various professional medical fields. Excelsior will keep taking root in the Asia market, the business scope includes Taiwan, Hong Kong, China

  16. Slide 16: Concrete ESG Implementation Results

    Concrete ESG Implementation Results 1.In 2023, our company successfully completed the ISO 14064-1 GHG inventory and assurance status ahead of schedule. We will continue to promote the completion of GHG inventories across all subsidiaries within the group. 2.In 2023, our company implemented a smart e

  17. Slide 17: Concrete ESG Implementation Results

    Concrete ESG Implementation Results 1.In 2023, we visited Taipei Zhaoru Senior Care Center to accompany the elderly in a dumpling-making event. In 2024, we organized a Dragon Boat Festival rice dumpling-making activity at Zhongli Smart Aging Academy for seniors with dementia and a recreational event

  18. Slide 18: Concrete ESG Implementation Results

    Concrete ESG Implementation Results 1.In 2022, we published our first Sustainability Report. In 2023, we emphasized SASB (Sustainability Accounting Standards Board) and TCFD (Task Force on Climate-Related Financial Disclosures) standards. 2.In 2023, we established the Sustainability Development Comm

  19. Slide 19: Growing up with Long-term partners

    Growing up with Long-term partners Excelsior has been operating for 30 years, accumulated core competitiveness with new ideas created, new models to integrate variously professional medical fields. Excelsior will keep take root in the Asia market, the business scope includes Taiwan, Hong Kong, China

Excelsior Medical — Investor Conference 2026 on 6ix